Who grade 4 glioma
Clinical trials for Who grade 4 glioma explained in plain language.
Never miss a new study
Get alerted when new Who grade 4 glioma trials appear
Sign up with your email to follow new studies for Who grade 4 glioma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising drug combo targets aggressive brain cancers in youth
Disease control Not yet recruitingThis study is for adolescents and young adults (ages 12-39) newly diagnosed with aggressive brain tumors called high-grade glioma or DIPG. The goal is to see if a combination of two immunotherapy drugs (relatlimab and nivolumab, sold as Opdualag) is safe and tolerable when given …
Matched conditions: WHO GRADE 4 GLIOMA
Phase 2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New hope for kids with deadly brain cancer: targeted drug trial launches
Disease control Not yet recruitingThis study tests a drug called tovorafenib in children and young adults (ages 1 to 39) newly diagnosed with aggressive brain tumors (high-grade glioma or DIPG) that have specific genetic changes. The goal is to see if the drug can help them live longer. About 79 participants will…
Matched conditions: WHO GRADE 4 GLIOMA
Phase 2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC